SEC Form 4 · accession 0001185185-17-002591
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Exec. Chairman & CEO · Director · 10% Owner
Period of report
Dec 7, 2017
Accepted (ET)
Dec 8, 2017 · 5:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 7, 2017 | S | 70,000 | $0.85 | D | 2,526,944 | D | |
| Common stock | Dec 7, 2017 | S | 30,000 | $0.86 | D | 2,496,944 | D | |
| Common stock | Dec 8, 2017 | S | 9,950 | $0.83 | D | 2,486,994 | D | |
| Common stock | Dec 8, 2017 | S | 10,000 | $0.84 | D | 2,476,994 | D | |
| Common stock | Dec 8, 2017 | S | 10,000 | $0.85 | D | 2,466,994 | D | |
| Common stock | Dec 8, 2017 | S | 5,000 | $0.88 | D | 2,461,994 | D | |
| Common stock | Dec 8, 2017 | S | 15,000 | $0.90 | D | 2,446,994 | D | |
| Common stock | Dec 8, 2017 | S | 5,000 | $0.91 | D | 2,441,994 | D |
Table II — derivative securities
No Table II lines on this filing.